FIELD: medicine; neurology; cardiology.
SUBSTANCE: invention relates to the field of medicine, in particular to neurology and cardiology, and it is intended for the differential diagnostics of subtypes of cryptogenic stroke (hereinafter – CS). A patient with CS is additionally subjected to an extended echocardiographic examination with an assessment of a function of the left atrium by the left atrium emptying fraction (hereinafter – LAEF), as well as determination of the concentration of N-terminal brain natriuretic peptide (hereinafter – NT-proBNP) fragment in serum on 4-7 day of the disease. At LAEF value of less than 51.8% and NT-proBNP concentration of more than 316 pg/ml, a cardioembolic subtype of CS is diagnosed; at LAEF value of more than 51.8% and NT-proBNP concentration of less than 316 pg/ml, a non-cardioembolic subtype of CS is diagnosed; at LAEF value of 51.8% and NT-proBNP concentration of less than 316 pg/ml, at LAEF value of less than 51.8% and NT-proBNP concentration of less than 316 pg/ml, or at LAEF value of more than 51.8% and NT-proBNP concentration of more than 316 pg/ml, a conclusion is made about the need for further examination.
EFFECT: invention provides an increase in the accuracy of differential diagnostics of subtypes of CS.
1 cl, 1 dwg, 2 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF LETHAL OUTCOME IN PATIENTS WITH ISCHEMIC STROKE | 2023 |
|
RU2817260C1 |
METHOD FOR PREDICTING POSITIVE RESPONSE TO CARDIAC CONTRACTILITY MODULATION THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTION AND ATRIAL FIBRILLATION | 2023 |
|
RU2807230C1 |
METHOD OF ASSESSING THE PROBABILITY OF LEFT ATRIAL APPENDAGE THROMBOSIS IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION | 2022 |
|
RU2798785C1 |
METHOD FOR PREDICTION OF MANIFESTED LEFT ATRIAL FIBROSIS IN PATIENTS WITH ATRIAL FIBRILLATION AND PRESERVED LEFT VENTRICULAR SYSTOLIC FUNCTION | 2024 |
|
RU2841227C1 |
METHOD FOR PREDICTION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH ISCHEMIC HEART DISEASE IN A COMBINATION WITH POSTINFARCTION LEFT VENTRICULAR ANEURYSM | 2019 |
|
RU2712629C1 |
METHOD FOR PREDICTION OF COMPLICATIONS IN CARDIOEMBOLIC ISCHEMIC STROKE WITH UNDERLYING HEPARIN THERAPY | 2024 |
|
RU2840929C1 |
METHOD FOR PREDICTION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH ISCHEMIC HEART DISEASE COMBINED WITH ISCHEMIC MITRAL INSUFFICIENCY | 2019 |
|
RU2712634C1 |
MIDREGIONAL PRO-ATRIAL NATRIURETIC PEPTIDE (pro-ANP) PRECURSOR APPLICABLE FOR IDENTIFYING PATIENTS WITH ATRIAL FIBRILLATION STARTED LESS THAN 48 HOURS EARLIER | 2012 |
|
RU2570755C2 |
METHOD FOR PHENOTYPING CHRONIC HEART FAILURE BASED ON METABOLOMIC PROFILING | 2024 |
|
RU2841230C1 |
METHOD FOR PREDICTING RISK OF CEREBRAL COMPLICATIONS FOLLOWING ISCHEMIC STROKE | 2014 |
|
RU2545435C1 |
Authors
Dates
2022-03-15—Published
2020-12-15—Filed